Frontiers in Oncology (Feb 2023)

A radiomic biomarker for prognosis of resected colorectal cancer liver metastases generalizes across MRI contrast agents

  • Jianan Chen,
  • Jianan Chen,
  • Helen M. C. Cheung,
  • Helen M. C. Cheung,
  • Paul J. Karanicolas,
  • Paul J. Karanicolas,
  • Natalie G. Coburn,
  • Natalie G. Coburn,
  • Guillaume Martel,
  • Guillaume Martel,
  • Albert Lee,
  • Albert Lee,
  • Chirag Patel,
  • Chirag Patel,
  • Laurent Milot,
  • Anne L. Martel,
  • Anne L. Martel

DOI
https://doi.org/10.3389/fonc.2023.898854
Journal volume & issue
Vol. 13

Abstract

Read online

IntroductionContrast-enhanced MRI is routinely performed as part of preoperative work-up for patients with Colorectal Cancer Liver Metastases (CRLM). Radiomic biomarkers depicting the characteristics of CRLMs in MRI have been associated with overall survival (OS) of patients, but the reproducibility and clinical applicability of these biomarkers are limited due to the variations in MRI protocols between hospitals.MethodsIn this work, we propose a generalizable radiomic model for predicting OS of CRLM patients who received preoperative chemotherapy and delayed-phase contrast enhanced (DPCE) MRIs prior to hepatic resection. This retrospective two-center study included three DPCE MRI cohorts (n=221) collected between January 2006 and December 2012. A 10-minute delayed Gd-DO3A-butrol enhanced MRI discovery cohort was used to select features based on robustness across contrast agents, correlation with OS and pairwise Pearson correlation, and to train a logistic regression model that predicts 3-year OS.ResultsThe model was evaluated on a 10-minute delayed Gd-DO3A-butrol enhanced MRI validation cohort (n=121), a 20-minute delayed Gd-EOB-DTPA (n=72) cohort from the same institute, and a 5-minute delayed Gd-DTPA cohort (n=28) from an independent institute. Two features were selected: minor axis length and dependence variance. The radiomic signature model stratified high-risk and low-risk CRLM groups in the Gd-DO3Abutrol (HR = 6.29, p = .007), Gd-EOB-DTPA (HR = 3.54, p = .003) and Gd-DTPA (HR = 3.16, p = .04) validation cohorts.DiscussionWhile most existing MRI findings focus on a specific contrast agent, our study shows the potential of MRI features to be generalizable across main-stream contrast agents at delayed phase.

Keywords